Renata Costa

Radiochemist at Itg Isotope Technologies Garching Gmbh

Renata Costa's Professional Contact Details

Email (Verified)

****@itg-garching.de

Get Email Address

+49 89 329898660

Location

MÃ¼nchen, Bayern, Germany

Company

Itg Isotope Technologies Garching Gmbh

Person Seniority

entry

Location Postal Code

80333

Renata Costa's Current Company Details

Itg Isotope Technologies Garching Gmbh

Garching bei MÃ¼nchen, Bayern, Germany • 28 Employees

pharmaceuticals

A New Generation of first-in-class Radionuclides ITG Isotopes Technologies Garching GmbH is a company of the ITM Group. ITM Isotopen Technologien MÃ¼nchen AG is a privately held group of companies dedicated to the development, production and global supply of innovative diagnostic and therapeutic radionuclides and radiopharmaceuticals. Furthermore, ITM and its subsidiaries are developing a proprietary portfolio and growing pipeline of targeted treatments in various stages of clinical development addressing a range of cancers such as neuroendocrine cancers or bone metastases. ITG GmbH offers radioisotopes for clinical applications as well as research purposes. We have therefore established a GMP manufacturing of a first-in-class radionuclides and -generator platform for the development of a new generation of targeted cancer diagnostics and therapies. Since 2007 the name ITG Isotopes Technologies Garching GmbH has stood for the highest level of quality and reliability in the sourcing, processing, radiolabeling and sales of radionuclides and for the marketing of devices. ITGÂ´s unrivaled logistics network allows guaranteed shipment within 24 hrs (Europe) and 72 hrs (Overseas) respectively. In July 2016 the European Commission has granted Marketing Authorization for EndolucinBetaÂ®. EndolucinBetaÂ® respectively no-carrier-added (n.c.a.) Lutetium (177Lu) chloride is a radiopharmaceutical precursor and is used in Targeted Radionuclide Therapy. This drug approval is an important milestone for the ITM Group. Our main objectives, together with our scientific, medical and industrial collaboration partners worldwide, are to significantly improve outcomes and quality of life for cancer patients while at the same time reducing side-effects and improving health economics through a new generation of Targeted Radionuclide Therapies in Precision Oncology. ITM â€“ PASSION FOR PRECSION. www.itm.ag

Founded Year

2007

Organization Website

itg-garching.de

Organization Languages

English

Current Technologies

1&1 hosting

apache

bootstrap framework

mobile friendly

typo3